Citric Acid → {1-[4-(8-Chloro-2-ethoxy-quinolin-4-yloxy)-2-(1-cyclopropoxysulfonylaminocarbonyl-2-ethyl-cyclopropylcarbamoyl)-pyrrolidine-1-carbonyl]-2,2-dimethyl-propyl}-carbamic acid 1-trifluoromethyl-cyclobutyl ester
Reaction equation
[Cl:1][C:2]1[CH:3]=[CH:4][CH:5]=[C:6]2[C:11]=1[N:10]=[C:9]([O:12][CH2:13][CH3:14])[CH:8]=[C:7]2[O:15][CH:16]1[CH2:20][N:19]([C:21](=[O:39])[CH:22]([NH:27][C:28]([O:30][C:31]2([C:35]([F:38])([F:37])[F:36])[CH2:34][CH2:33][CH2:32]2)=[O:29])[C:23]([CH3:26])([CH3:25])[CH3:24])[CH:18]([C:40]([NH:42][C:43]2([C:48]([OH:50])=O)[CH2:45][CH:44]2[CH2:46][CH3:47])=[O:41])[CH2:17]1.C(N([CH:57]([CH3:59])[CH3:58])C(C)C)C.CN(C(ON1N=NC2C=CC=NC1=2)=[N+](C)C)C.F[P-](F)(F)(F)(F)F.C1([O:87][S:88](=[O:91])(=[O:90])[NH2:89])CC1.C1CCN2C(=NCCC2)CC1.C(O)(=O)CC(CC(O)=O)(C(O)=O)O>CN(C=O)C>[F:38][C:35]([F:36])([F:37])[C:31]1([O:30][C:28](=[O:29])[NH:27][CH:22]([C:21]([N:19]2[CH2:20][CH:16]([O:15][C:7]3[C:6]4[C:11](=[C:2]([Cl:1])[CH:3]=[CH:4][CH:5]=4)[N:10]=[C:9]([O:12][CH2:13][CH3:14])[CH:8]=3)[CH2:17][CH:18]2[C:40](=[O:41])[NH:42][C:43]2([C:48]([NH:89][S:88]([O:91][CH:57]3[CH2:59][CH2:58]3)(=[O:90])=[O:87])=[O:50])[CH2:45][CH:44]2[CH2:46][CH3:47])=[O:39])[C:23]([CH3:25])([CH3:26])[CH3:24])[CH2:34][CH2:33][CH2:32]1Participants
Reactant 6
Product 1
Reagents, catalysts & solvents 1
Procedure
To 1-({4-(8-chloro-2-ethoxy-quinolin-4-yloxy)-1-[3,3-dimethyl-2-(1-trifluoromethyl-cyclobutoxycarbonylamino)-butyryl]-pyrrolidine-2-carbonyl}-amino)-2-ethyl-cyclopropanecarboxylic acid (110 mg, 0.15 mmol) in DMF (3 mL, 0.05 M) was added i-Pr2EtN (90 μL, 0.38 mmol) and HATU (86 mg, 0.23 mmol) and stirred 1 h at rt. To the reaction mixture at rt was added sulfamic acid cyclopropyl ester (46 mg, 0.30 mmol) and DBU (90 μL, 0.60 mmol). The reaction was stirred 17 h at rt, and then added to 5% aq citric acid and extracted with ethyl acetate. The combined organic extracts were washed water, and brine, and subsequently dried over magnesium sulfate. Concentration, followed by purification by reverse phase HPLC and lyophilization gave {1-[4-(8-chloro-2-ethoxy-quinolin-4-yloxy)-2-(1-cyclopropoxysulfonylaminocarbonyl-2-ethyl-cyclopropylcarbamoyl)-pyrrolidine-1-carbonyl]-2,2-dimethyl-propyl}-carbamic acid 1-trifluoromethyl-cyclobutyl ester (20 mg, 16% yield) as a white powder. 1H NMR (CD3OD, 500 MHz) δ 9.18 (s, 1H), 7.95 (d, 1H), 7.70 (d, 1H), 7.20 (dd, 1H), 6.48 (s, 1H), 5.4 (br s, 1H), 4.45-4.6 (m, 4H), 4.2-4.3 (m, 2H), 2.58-2.62 (m, 1H), 2.2-2.4 (m, 4H), 1.5-1.7 (m, 4H), 1.43 (t, 3H), 1.2-1.3 (m, 3H) 1.2 (dd, 2H), 1.1-0.9 (m, 13H), 0.85 (m, 2H). LCMS found 846.00 [M+H]+.
Workup
- stirringThe reaction was stirred 17 h at rt
- extractionextracted with ethyl acetate
- washThe combined organic extracts were washed water, and brine
- dry with materialsubsequently dried over magnesium sulfate
- concentrationConcentration
- customfollowed by purification by reverse phase HPLC and lyophilization
Sources & evidence
- ORD record
- ord-b1d7043c55b348c0b36b42a731d0a76a
- Source dataset
- uspto-grants-2013_08
- Patent number
- US08513186B2
Reaction notes
Loading…